Kuros Biosciences AG

BRIEF

published on 11/19/2024 at 07:05, 1 month 2 days ago

Kuros Biosciences Expands into Extremities Markets

Kuros Biosciences Market Expansion Orthopedic Innovation Extremities Markets MagnetOs Technology
PRESS RELEASE

published on 11/19/2024 at 07:00, 1 month 2 days ago

Kuros Biosciences Expands into Extremities Markets
Kuros Biosciences expands into extremities markets with strategic appointment of Vice President and Surgeon Advisory Board. Company leverages MagnetOs technology for improved fusion outcomes

Medical Devices Kuros Biosciences Market Expansion Bone Healing Technologies Extremities Markets
BRIEF

published on 10/10/2024 at 07:05, 2 months 11 days ago

Kuros Biosciences Reports Significant Sales Growth and Exceeds Cash Flow Breakeven

Financial Performance Kuros Biosciences Market Expansion MagnetOs Sales Rise Project Fusion
PRESS RELEASE

published on 10/10/2024 at 07:00, 2 months 11 days ago

Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024
Kuros Biosciences reports 149% increase in direct MagnetOs sales and surpasses cash flow breakeven in the first nine months of 2024. Company's financial highlights and future outlook highlighted

Financial Performance Kuros Biosciences MagnetOs Sales Future Outlook Cash Flow Breakeven
BRIEF

published on 08/08/2024 at 07:05, 4 months 13 days ago

Kuros Biosciences Reports First Half of 2024 Results

Clinical Study EBITDA Improvement MagnetOs Sales Growth H1 2024 Results FDA Clearances
PRESS RELEASE

published on 08/08/2024 at 07:00, 4 months 13 days ago

Kuros Biosciences Reports First Half of 2024 Results
Kuros Biosciences reports significant growth in H1 2024, with MagnetOs sales up 159% to CHF 31.6 million. FDA clearances and positive outlook indicate continued success in bone healing technologies market

Sales Growth Kuros Biosciences MagnetOs H1 2024 FDA Clearances
BRIEF

published on 06/25/2024 at 07:05, 5 months 26 days ago

Kuros Biosciences Publishes Superior MAXA Study Outcomes in Spine

Kuros Biosciences MagnetOs Spinal Fusion MAXA Study Autograft
PRESS RELEASE

published on 06/25/2024 at 07:00, 5 months 26 days ago

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Kuros Biosciences announces the publication of MagnetOs MAXA Level 1 study outcomes in Spine, showing superiority over autograft. Study details effectiveness of MagnetOs in posterolateral fusions

Kuros Biosciences MagnetOs MAXA Level 1 Spine Study Bone Healing Technologies
BRIEF

published on 04/24/2024 at 07:05, 7 months 27 days ago

Kuros Biosciences Reports Strong Growth in Q1 2024

FDA 510(k) Clearance Clinical Study Kuros Biosciences Q1 2024 Growth MagnetOs Sales Increase
PRESS RELEASE

published on 04/24/2024 at 07:00, 7 months 27 days ago

Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Kuros Biosciences reports strong Q1 2024 performance with 155% increase in direct MagnetOs sales. FDA clearance for MagnetOs Putty and positive EBITDA. Joe Ross appointed SVP Marketing

FDA Clearance Kuros Biosciences MagnetOs Sales Q1 2024 Performance Joe Ross

Published on 12/21/2024 at 01:30, 17 hours 30 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 30 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 55 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 30 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 9 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 15 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 50 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 42 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News